Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sequence specificity of drug-DNA interactions.

J C Dabrowiak

    Life Sciences
    |June 27, 1983
    PubMed
    Summary

    Researchers present methods to identify DNA sequences targeted by anticancer drugs, carcinogens, and mutagens. Techniques like "footprinting" analysis reveal sequence preferences for agents interacting with DNA, aiding drug development and safety assessments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Drug-RNA footprinting.

    Methods in enzymology·2001
    Same author

    Characterization of hairpin-duplex interconversion of DNA using polyacrylamide gel electrophoresis.

    Biophysical chemistry·2001
    Same author

    Binding of human immunodeficiency virus type 1 nucleocapsid protein to psi-RNA-SL3.

    Biophysical chemistry·2000
    Same author

    Monomer-dimer equilibrium constants of RNA in the dimer initiation site of human immunodeficiency virus type 1.

    Biochemistry·1999
    Same author

    Kinetic analysis of drug cleavage of closed-circular DNA.

    Biophysical chemistry·1998
    Same author

    Quantitation of ethidium-stained closed circular DNA in agarose gels.

    Journal of biochemical and biophysical methods·1997

    Area of Science:

    • Biochemistry
    • Molecular Biology
    • Pharmacology

    Background:

    • Understanding how drugs, carcinogens, and mutagens interact with DNA is crucial for developing effective treatments and assessing risks.
    • Sequence-specific interactions dictate the efficacy and toxicity of DNA-targeting agents.

    Purpose of the Study:

    • To present methodologies for determining the DNA sequence specificities of various exogenous agents.
    • To explore how different interaction mechanisms (covalent binding vs. equilibrium binding) influence the determination of sequence preferences.

    Main Methods:

    • Directly determining DNA sequences for agents that covalently bind or nick DNA, leaving a permanent record.
    • Utilizing "footprinting" analysis, a technique adapted from protein-DNA binding studies, for agents that interact with DNA in an equilibrium fashion.
    • Characterizing the sequence specificities of small ligands interacting with natural DNA.

    Main Results:

    • Established methods for identifying specific DNA sequences recognized by anticancer drugs, carcinogens, and mutagens.
    • Demonstrated the utility of "footprinting" for studying equilibrium-based drug-DNA interactions.
    • Presented sequence specificities for several small molecule ligands.

    Conclusions:

    • The presented methods provide a framework for understanding sequence-specific drug-DNA interactions.
    • These techniques are valuable for the rational design of anticancer drugs and the assessment of environmental mutagens.
    • Further characterization of ligand-DNA interactions can lead to novel therapeutic strategies.

    Related Experiment Videos